Cargando…
Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
Autores principales: | De Groot, AS, Moise, L, Koita, O, Sangare, K, Levitz, L, Rozenhal, J, Koty, Z, Tounkara, K, Ardito, M, Boyle, CM, Rochas, M, Martin, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441331/ http://dx.doi.org/10.1186/1742-4690-9-S2-P295 |
Ejemplares similares
-
Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012) -
Evaluating short-term patient outcomes after HIV care interventions in a low resource setting: preparing for an HIV vaccine trial site in Bamako, Mali
por: Koty, Z, et al.
Publicado: (2012) -
A decade of partnering to stop HIV in West Africa: GAIA VF prevention, education, access to care and vaccine trial site development in Bamako, Mali
por: De Groot, A, et al.
Publicado: (2012) -
Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes
por: Leviyang, Sivan, et al.
Publicado: (2015) -
Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
por: Poole, D, et al.
Publicado: (2012)